The Hepatitis B Virus (HBV) treatment market is witnessing steady growth due to rising global disease burden, increasing awareness, and continuous advancements in antiviral therapies. Hepatitis B remains a major public health challenge worldwide, particularly in Asia-Pacific and Africa, where infection rates remain high. According to industry analysis, the Hepatitis B Virus Treatment Market is expected to grow from US$ 5.3 billion in 2025 to US$ 9.87 billion by 2034, registering a CAGR of 7.14% from 2026 to 2034.

Read More - https://www.theinsightpartners.....com/reports/hepatit